RSV Prevention, Part III: Older Adult Vaccination

  • This page as PDF

Summary

Tune into the third episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the future of RSV among older adults.
“Historically, vaccines have targeted children, but immunizations for older adults are becoming increasingly common and necessary. ” Thomas Hess

Panelists

Moderator
Elif Alyanak , Associate Principal, Policy

Elif Alyanak supports clients with evidence-based research and analysis that spans a variety of healthcare sectors and stakeholders.

Speaker
Alessandra Fix , Associate Principal, Policy

Alessandra Fix supports clients from a variety of healthcare sectors in understanding and navigating the healthcare landscape through research, analysis, and strategic advisory services.

Speaker
Thomas Hess , Principal, Market Access & Reimbursement

Thomas Hess brings over 15 years of successful leadership experience to his role at Avalere Health.

If you would like to watch the video version, please visit our video page. To learn more about this topic, check out our insight Navigating the Road to RSV Prevention. 

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Vaccines and Public Health
Please enter your email address to be notified when new Vaccines and Public Health insights are published.

Back To Top